Patent applications and USPTO patent grants for Fresenius Kabi USA, LLC.The latest application filed is for "fulvestrant formulations".
Patent | Date |
---|---|
Fluid delivery event tracking and transaction management Grant 11,446,437 - Ambrosina , et al. September 20, 2 | 2022-09-20 |
Fulvestrant Formulations App 20220143044 - FARAJ; Jabar A. | 2022-05-12 |
Impact Resistant And Tamper Evident System For Prefilled Syringe App 20220118190 - MURRAY; Christopher J. | 2022-04-21 |
Tamper evident assembly for syringes Grant 11,305,072 - Murray , et al. April 19, 2 | 2022-04-19 |
Levothyroxine Liquid Formulations App 20220096414 - USAYAPANT; Arunya ;   et al. | 2022-03-31 |
Fulvestrant formulations Grant 11,229,655 - Faraj January 25, 2 | 2022-01-25 |
Levothyroxine liquid formulations Grant 11,135,190 - Usayapant , et al. October 5, 2 | 2021-10-05 |
Levothyroxine Liquid Formulations App 20210251931 - USAYAPANT; Arunya ;   et al. | 2021-08-19 |
Tamper Evident Assembly With Rfid For Syringes App 20210236736 - MURRAY; Christopher J. ;   et al. | 2021-08-05 |
Tamper Evident Cap With Rfid For Syringes App 20210236744 - MURRAY; Christopher J. ;   et al. | 2021-08-05 |
Propofol Formulations With Non-reactive Container Closures App 20210128407 - DESAI; Neil P. ;   et al. | 2021-05-06 |
Propofol formulations with non-reactive container closures Grant 10,772,795 - Desai , et al. Sept | 2020-09-15 |
Tamper Evident Cap For Syringes App 20200238023 - MURRAY; Christopher J. ;   et al. | 2020-07-30 |
Methods for analysis of protamine Grant 10,684,286 - Torralba , et al. | 2020-06-16 |
Tamper Evident Assembly For Syringes App 20200164161 - MURRAY; Christopher J. ;   et al. | 2020-05-28 |
Tamper evident cap for syringes Grant 10,661,030 - Murray , et al. | 2020-05-26 |
Tamper evident cap for syringes Grant 10625030 - | 2020-04-21 |
Levothyroxine Liquid Formulations App 20190336463 - USAYAPANT; Arunya ;   et al. | 2019-11-07 |
Plunger Rod For Under-filled Syringes App 20190290857 - FERRARO; Anthony D. | 2019-09-26 |
Levothyroxine liquid formulations Grant 10,398,669 - Usayapant , et al. Sep | 2019-09-03 |
Fulvestrant Formulations App 20190151333 - FARAJ; Jabar A. | 2019-05-23 |
Caspofungin Acetate Formulations App 20190105392 - Jiang; John ;   et al. | 2019-04-11 |
Fulvestrant formulations Grant 10,188,663 - Faraj Ja | 2019-01-29 |
Propofol Formulations With Non-reactive Container Closures App 20190000714 - DESAI; Neil P. ;   et al. | 2019-01-03 |
Levothyroxine Liquid Formulations App 20180153838 - USAYAPANT; Arunya ;   et al. | 2018-06-07 |
Propofol formulations with non-reactive container closures Grant 9,925,117 - Desai , et al. March 27, 2 | 2018-03-27 |
Fulvestrant Formulations App 20180050046 - FARAJ; Jabar A. | 2018-02-22 |
Fulvestrant formulations Grant 9,833,459 - Faraj December 5, 2 | 2017-12-05 |
Caspofungin Acetate Formulations App 20170296667 - Jiang; John ;   et al. | 2017-10-19 |
Levothyroxine liquid formulations Grant 9,782,376 - Usayapant , et al. October 10, 2 | 2017-10-10 |
Methods For Analysis Of Protamine App 20170248605 - TORRALBA; Pearle ;   et al. | 2017-08-31 |
Methods for analysis of protamine Grant 9,664,685 - Mowli , et al. May 30, 2 | 2017-05-30 |
Caspofungin acetate formulations Grant 9,636,407 - Jiang , et al. May 2, 2 | 2017-05-02 |
Caspofungin Acetate Formulations App 20160310597 - Jiang; John ;   et al. | 2016-10-27 |
Propofol Formulations with Non-Reactive Container Closures App 20160235626 - DESAI; Neil P. ;   et al. | 2016-08-18 |
Fulvestrant Formulations App 20160129014 - FARAJ; Jabar A. | 2016-05-12 |
Fulvestrant formulations Grant 9,271,990 - Faraj March 1, 2 | 2016-03-01 |
Levothyroxine Formulations App 20160015641 - Jiang; John Zhiqiang ;   et al. | 2016-01-21 |
Levothyroxine formulations Grant 9,168,238 - Jiang , et al. October 27, 2 | 2015-10-27 |
Levothyroxine formulations Grant 9,168,239 - Jiang , et al. October 27, 2 | 2015-10-27 |
Fulvestrant Formulations App 20150231153 - FARAJ; Jabar A. | 2015-08-20 |
Propofol formulations with non-reactive container closures Grant 9,072,655 - Desai , et al. July 7, 2 | 2015-07-07 |
Propofol formulations with non-reactive container closures Grant 9,072,656 - Desai , et al. July 7, 2 | 2015-07-07 |
Levothyroxine Formulations App 20150182484 - Jiang; Zhi-Qiang ;   et al. | 2015-07-02 |
Levothyroxine Formulations App 20150174246 - Jiang; Zhi-Qiang ;   et al. | 2015-06-25 |
Methods For Analysis Of Protamine App 20150104785 - MOWLI; Jay ;   et al. | 2015-04-16 |
Levothyroxine formulations Grant 9,006,289 - Jiang , et al. April 14, 2 | 2015-04-14 |
Bortezomib formulations Grant 8,962,572 - Usayapant , et al. February 24, 2 | 2015-02-24 |
Propofol formulations with non-reactive container closures Grant 8,889,346 - Desai , et al. November 18, 2 | 2014-11-18 |
Tigecycline Formulations App 20140323443 - UCHIL; Beena ;   et al. | 2014-10-30 |
Sustained-release Microspheres And Methods Of Making And Using Same App 20140322336 - WOO; Byung Ho ;   et al. | 2014-10-30 |
Voriconazole Formulations App 20140275122 - Uchil; Beena ;   et al. | 2014-09-18 |
Sustained-release microspheres and methods of making and using same Grant 8,808,746 - Woo , et al. August 19, 2 | 2014-08-19 |
Propofol Formulations with Non-Reactive Container Closures App 20140224694 - DESAI; Neil P. ;   et al. | 2014-08-14 |
Propofol Formulations with Non-Reactive Container Closures App 20140224693 - DESAI; Neil P. ;   et al. | 2014-08-14 |
Propofol Formulations with Non-Reactive Container Closures App 20130327668 - DESAI; Neil P. ;   et al. | 2013-12-12 |
Levothyroxine Formulations App 20130053445 - Jiang; Zhi-Qiang ;   et al. | 2013-02-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.